ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,745.37
0.40%
US Tech 100
19,551.60
-0.14%
Dow Jones
42,175.11
0.62%
Brent Oil
71.085
0.19%
Bitcoin
65,763.07
0.89%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) News

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTYX
DateTimeSourceHeadlineSymbolCompany
09/23/20248:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
09/23/20248:00AMGlobeNewswire Inc.Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiNASDAQ:VTYXVentyx Biosciences Inc
09/09/20244:47PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
09/06/20248:00AMGlobeNewswire Inc.Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
08/30/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
08/30/20248:00AMGlobeNewswire Inc.Ventyx Biosciences Announces Departure of Chief Financial OfficerNASDAQ:VTYXVentyx Biosciences Inc
08/28/20248:00AMGlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
08/13/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
08/13/20244:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
08/08/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
08/08/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
08/08/20244:01PMGlobeNewswire Inc.Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
07/29/20248:00AMGlobeNewswire Inc.Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
06/11/20244:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
06/05/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
06/05/20244:01PMGlobeNewswire Inc.Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory MarkersNASDAQ:VTYXVentyx Biosciences Inc
05/16/20244:05PMGlobeNewswire Inc.Ventyx Biosciences to Participate in Three Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
05/16/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
05/16/20248:00AMGlobeNewswire Inc.Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating OfficerNASDAQ:VTYXVentyx Biosciences Inc
05/09/20244:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
05/09/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
05/09/20244:01PMGlobeNewswire Inc.Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
05/02/20244:05PMGlobeNewswire Inc.Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTYXVentyx Biosciences Inc
04/26/20245:45AMPR Newswire (US)The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYXNASDAQ:VTYXVentyx Biosciences Inc
04/19/20246:00AMPR Newswire (US)Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
04/16/20245:45AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYXNASDAQ:VTYXVentyx Biosciences Inc
04/12/20245:45AMPR Newswire (US)The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYXNASDAQ:VTYXVentyx Biosciences Inc
04/09/20246:10AMPR Newswire (US)Investors in Ventyx Biosciences, Inc. Should Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
04/05/20245:45AMPR Newswire (US)Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact The Gross Law Firm about pending Class Action - VTYXNASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

Your Recent History

BIT
P45438
Bnp Paribas Issuance
BIT
UC1C4S
Unicredit Bank
BIT
P1SSL2
BNP Paribas Issuance
BIT
P1TY92
BNP Paribas Issuance
BIT
P1CSK8
BNP Paribas Issuance
BIT
S27206
Societe Generale Effekten
BIT
P1MKP3
BNP Paribas Issuance
BIT
P1SWS9
BNP Paribas Issuance
BIT
P1V7F0
NLBNPIT1V7F0 20351219 73...
BIT
UV8B4A
UniCredit Bank
BIT
I04617
Banca IMI
BIT
S27873
Societe Generale Effekten
BIT
P10QU6
Bnp Paribas Issuance
BIT
F36113
Vontobel Financial Produ...
BIT
FGRTEC
Vontobel Financial Produ...
BIT
P1Y3W1
NLBNPIT1Y3W1 20351221 2....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved